The mission of the Biostatistics Shared Resource is to provide strategic service in the design, oversight, implementation, analysis, publication, and reporting of scientific studies by CCSG program members. This includes articulating study objectives and hypotheses, conceiving appropriate cost-effective designs and models for achievement of study objectives, assuring that modern and appropriate statistical methods are used, monitoring interim and final analyses, and co-authoring abstracts and manuscripts. The expertise provided by the staff ensures that the yield of useful information from scientific studies is maximized while the costs are minimized. With leadership including William Brady, PhD (ET) as Resource Director;Alan Hutson, PhD (ET), as Chair of RPCI's Department of Biostatistics and Bioinformatics;Gregory Wilding, PhD (GU), as departmental Vice Chair for Biostatistics and Resource Co-Director;and several newly appointed PhD biostatisticians, the Resource has continued to expand upon its technical, collaborative, and administrative expertise. Dr. Hutson (ET) is also Chair of Biostatistics at the State University of New York at Buffalo (UB);and the Biostatistics Shared Resource is a joint effort between the RPCI and UB departments. The Biostatistics Resource and the Bioinformatics Resource (Song Liu, PhD (GN), Vice-Chair for Bioinformatics and Resource Director) coordinate several research activities through regular planning meetings. The expertise within the Resource spans the full range of biostatistics (from preclinical studies to clinical trials, epidemiology, and diagnostic tests), molecular epidemiology, and statistical genetics and genomics. The Resource is fully ingrained in the scientific collaborative process with CCSG members throughout the Institute, and further usage is fostered by numerous mechanisms, including: referrals, the Scientific Review Committee's requirement that protocols have input from a biostatistician, mandates by funding agencies that proposals include proper statistical designs, formal seminars given by Resource staff, and presentations at CCSG Program meetings. First priority for use of the Biostatistics Shared Resource is given to peer-review-funded CCSG members; second to non-peer-review-funded CCSG members;third to non-members and academic collaborators;and lastly to external users. During the reporting period, the Biostatistics Shared Resource served 119 members, with 34% utilization by CCSG members with peer reviewed funding. The CCSG support provides 22% of the overall proposed budget.

Public Health Relevance

Rigorous biostatistics is central to all aspects of cancer research. The Biostatistics Shared Resource plays a central role in the design, analysis, and interpretation of basic science, clinical, and population-based cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-37
Application #
8738387
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-06-16
Project End
2019-04-30
Budget Start
2014-06-26
Budget End
2015-04-30
Support Year
37
Fiscal Year
2014
Total Cost
$410,081
Indirect Cost
$162,203
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Zhao, Zhiguo; Wen, Wanqing; Michailidou, Kyriaki et al. (2016) Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes Control 27:679-93
Goossens, Maria E; Isa, Fatima; Brinkman, Maree et al. (2016) International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics. Arch Public Health 74:30
Clyde, Merlise A; Palmieri Weber, Rachel; Iversen, Edwin S et al. (2016) Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. Am J Epidemiol 184:579-589
Wilton, John; Kurenova, Elena; Pitzonka, Laura et al. (2016) Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs. Eur J Drug Metab Pharmacokinet 41:55-67
Sexton, Sandra; Tulowitzki, Ryan; Jones, Craig A et al. (2016) Involvement of the renin-angiotensin system in the development of nephrogenic systemic fibrosis-like lesions in the RenTag mouse model. Clin Exp Nephrol 20:162-8
Shafirstein, Gal; Battoo, Athar; Harris, Kassem et al. (2016) Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future Directions. Ann Am Thorac Soc 13:265-75
Pharoah, Paul D P; Song, Honglin; Dicks, Ed et al. (2016) PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. J Natl Cancer Inst 108:
Austin, David C; Strand, Douglas W; Love, Harold L et al. (2016) NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Prostate 76:1004-18
Rohrbach, Daniel J; Rigual, Nestor; Arshad, Hassan et al. (2016) Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma. J Biomed Opt 21:18002
Chinnam, Meenalakshmi; Wang, Xiaoling; Zhang, Xiaojing et al. (2016) Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice. Mol Cell Biol 36:1621-7

Showing the most recent 10 out of 1099 publications